PDGFRB and neoplasm: Abnormal expression and overactivation of RTKs, including vascular endothelial growth factor receptor (VEGFR), epidermal growth factor receptor (EGFR), and platelet-derived growth factor receptor (PDGFR) are associated with tumor invasion, metastasis, and tumor angiogenesis (5).